What people usually mean by exosome therapy
“Exosome therapy” usually points at preparations marketed as extracellular vesicles or vesicle-rich products. Clinics may bundle the label with IV menus, joint injections, aesthetic packages, or stem-cell-adjacent language. The marketing label is not a single standardized product.
In research conversation, vesicles are a broad biology topic. Clinic product quality, sourcing, processing, and claims vary widely. A homepage slogan is not the same as a characterized product with clear framing for your use case.
What we do not claim here: that exosome products reverse disease, regenerate organs, or guarantee anti-aging results. We do not publish “best exosome clinics.”
Questions for a consult (no prescribing)
Bring concrete questions. Copy them into a note. These are literacy prompts, not a treatment plan:
What exactly is in the preparation you plan to use, and how is it labeled and sourced on the consent form?
2. Who oversees the visit, including credentials, and who administers the product?
3. What outcome are you aiming for in my case, and how will we measure it without guaranteeing results?
4. What adverse events have you seen, and what is the follow-up plan?
5. What does this cost fully, including product, visits, and add-ons, and what is refundable if I stop early?
6. Are you recommending this instead of, or alongside, conventional care I already have?
7. How do you distinguish this offer from stem-cell offerings on the same site, without marketing blur?
Red flags
Payment never buys organic rank or a kinder evidence grade. See How we vet clinics (/about/how-we-vet-clinics) and How we make money (/about/how-we-make-money).
Clinic owners: Claim your clinic (/claim) and For clinics (/for-clinics).
Related reading
Blog literacy: Exosome therapy article (/blog/exosome-therapy/), which is a blog article and not a Treatment Guide.
Stem cell therapy (/treatments/stem-cell-therapy) and Peptide therapy (/treatments/peptide-therapy).
State of regenerative clinics 2026 (/research/state-of-regenerative-clinics-2026), B-07.
How we vet clinics (/about/how-we-vet-clinics) and Editorial policy (/about/editorial-policy).
Hard cure language; pressure to pay today; “no risk” claims; refusing to name the product; using Directory Featured placement or Score as proof of superiority. Featured is labeled paid placement when enabled, and Score ≠ spend. See How we make money (/about/how-we-make-money).
More patient-trust framing: clinic costs and red flags (/guides/regenerative-clinic-cost-and-red-flags) when D-05 is published.
Finding clinics on Regenerated (Directory CTA)
Start at the live exosome therapy Directory hub (/clinics/t/exosome-therapy), which returns 200. Use the main clinic Directory (/clinics) as a fallback. Directory pages help you browse listings. Do not treat inclusion, Featured placement, or Score as proof of outcomes, and do not invent clinics.
How this differs from stem-cell marketing
Ads sometimes blur exosomes with stem cells, “cellular rejuvenation,” or anti-aging promises. Those are different claims with different evidence bars. If a page collapses them into one miracle story, treat that as a shopping red flag.
Ask for the exact product identity, sourcing, and regulatory framing in writing, not Instagram synonyms. Related Directory literacy, not endorsements: stem-cell therapy clinics (/clinics/t/stem-cell-therapy) and peptide therapy clinics (/clinics/t/peptide-therapy) when you are comparing modality menus.
Editorial standards: Editorial policy (/about/editorial-policy).
